|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows used in operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation of property and equipment | |||||
| Amortization of debt costs | |||||
| Accretion of investment discount | |||||
| Non-cash interest expense related to Senior Secured Convertible Note | |||||
| Share-based compensation expense | |||||
| Loss on disposals of property and equipment | |||||
| Changes in operating assets and liabilities: | |||||
| License receivable | |||||
| Other receivables | |||||
| Research and development tax credits receivable | |||||
| Prepaid expenses | |||||
| Inventory | |||||
| Operating lease assets and liabilities | |||||
| Accounts payable and accrued liabilities | |||||
| Net cash used in operating activities | |||||
| Cash provided by investing activities | |||||
| Acquisition of property and equipment | |||||
| Acquisition of short-term investments | |||||
| Redemption of short-term investments | |||||
| Net cash provided by investing activities | |||||
| Cash provided by financing activities | |||||
| Proceeds from exercise of options | |||||
| Proceeds from issuance of pre-funded warrants, net of issuance costs | |||||
| Proceeds from issuance of common stock warrants, net of issuance costs | |||||
| Series A common warrants | |||||
| Series B common warrants | |||||
| Proceeds from exercise of warrants, net of issuance costs | |||||
| Series A common warrants | |||||
| Series B common warrants | |||||
| Proceeds from issuance of senior secured convertible debt | |||||
| Pre-funded warrant issuance costs | |||||
| Proceeds from employee stock purchase plan | |||||
| Payment of debt issuance costs | |||||
| Cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents - Beginning of period | |||||
| Cash and cash equivalents - End of period | |||||
Loading...